Increased pigmentation in scleroderma

Journal of Rheumatology

Volumn 23, Issue 11, 1996, Pages 1912-1916

  Pope, Janet E ^a,b   Shum, David T ^a   Gottschalk, Ron ^a   Stevens, Adam ^a   McManus, Ruth ^a  

^a Department of Medicine ^*  (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Biopsy; Pigmentation; Scleroderma

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PIGMENTATION; PRIORITY JOURNAL; SCLERODERMA; SKIN BIOPSY;

ADRENOCORTICOTROPIC HORMONE; AGED; BIOPSY; FEMALE; HUMANS; HYDROCORTISONE; MALE; MELANINS; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SKIN; SKIN DISEASES; SKIN PIGMENTATION;

EID: 0029858018     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Medsger TA Jr: Systemic sclerosis (scleroderma), eosinophilic fasciitis, and calcinosis. In: McCarty DJ, ed. Arthritis and Allied Conditions, 10th ed. Philadelphia: Lea and Febiger, 1985;994-1036.
2. Le Roy EC, Black C, Fleischmajer R, et al: Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-4.
3. Sanchez JL, Vasquez M, Sanches NP: Vitiligo like macules in systemic scleroderma. Arch Dermatol 1983;119:129-33.
4. Fitzpatrick TB, Mosher DB: Pigmentation of the skin and disorders of melanin metabolism. In: Petersdorf RG, Adams RD, eds. Harrison's Principles of Internal Medicine, 10th ed. New York: McGraw-Hill, 1983:265-73.
5. Fleischmajer R, Perlish JS, Reeves IRT: Cellular infiltrates in scleroderma skin. Arthritis Rheum 1977;20:975-84.
6. Cash JM, Crofford LJ, Gallucci WT, et al: Pituitary-adrenal axis responsiveness to bovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low dose prednisone. J Rheumatol 1992;19:1692-6.
7. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS: Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992;35:1281-8.
8. Preliminary criteria for the classification of systemic sclerosis (scleroderma): Special article. Arthritis Rheum 1980;23:58l-90.
9. Cochrane AJ: The incidence of melanocytes in normal skin. J Invest Dermatol 1970;55:65-70.
10. Lever WF, Schaumburg-Lever G: Morphology of the cells in the dermal infiltrate. In: Lever WF, Schaumburg-Lever G, eds. Histopathology of the Skin, 7th ed. Philadelphia: JB Lippincott 1990:62-3.
11. Kehlet H, Blichert-Toft M, Lindholm J, et al: Short ACTH test in assessing hypothalamic-pituitary-adrenocortical function. BMJ 1976;1:249-51.
12. Blake Tyrell J, Findling JW, Arcon DC: Hypothalamus and pituitary. In: Greenspan FS, Baxter JD, eds. Basic and Clinical Endocrinology, 4th ed. Norwalk CT: Appleton & Lange, 1994, 83-4.
13. Jawitz JC, Albert MK, Nigra TP, Bunning RD: A new skin manifestation of progressive systemic sclerosis. J Am Acad Dermatol 1984;11:265-8.
14. Fam AG, Lee P: The belt sign in scleroderma. J Rheumatol 1990;17:725-6.
15. Sukenik S, Buskila D, Kleiner-Baumgarten A: Hyperpigmentation of the skin along the thoracic and lumbar spine in progressive systemic sclerosis. J Rheumatol 1991;18:1946-7.
16. Tuffanelli DL, Winkelmann RK: Systemic scleroderma. A clinical study of 727 cases. Arch Dermatol 1961;84:359-71.
17. Franks AG: Recognizing scleroderma-caused skin changes. J Musculoskeletal Med 1989;6:56-74.
18. Cabrai A, Castor CW: Connective tissue activation XXVII. The behavior of skin fibroblasts from patients with scleroderma. Arthritis Rheum 1983;26:1362-9.
19. Clements PJ, Lachenbruch PA, Ng SC, et al: Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 1990;33:1256-63.
20. Medsger TA Jr, Masi AT: Epidemiology of progressive systemic sclerosis. Clin Rheum Dis 1979;5:15-25.